Yahoo Finance Live anchors discuss reports that Apple has ditched plans to increase iPhone 14 production.
Shares of Biogen (NASDAQ: BIIB) were skyrocketing 36% as of 11:10 a.m. ET on Wednesday. The huge gain came after the company and its partner Eisai (OTC: ESALY) announced positive results on Tuesday from their late-stage Clarity AD study evaluating lecanemab in treating Alzheimer's disease. The news also propelled two stocks of other drugmakers developing Alzheimer's disease drugs significantly higher.
Yahoo Finance's Allie Garfinkle discusses news that Apple has asked suppliers to pull back production by up to 6 million units and what it signals about consumer demand ahead of the holiday season.
Yahoo Finance Live anchors discuss Biogen stock performance on promising Alzheimer’s drug trial data.
Atlantic Equities analyst Hamilton Faber upgraded Netflix stock to overweight (buy) from neutral (hold), while simultaneously boosting his price target to $283, up from its former level of $211. The analyst cited the debut of Netflix's upcoming ad-supported tier, which he believes "could be extremely material" for the streaming service, the benefits of which haven't yet been accurately reflected in analysts' consensus estimates. Faber estimates that Netflix could generate average revenue per user (ARPU) of $26 per month from advertising, more than three times the rate of Disney's Hulu.
In this article, we will be taking a look at the 10 companies that are buying back their stock in 2022. To skip our detailed analysis of these companies, you can go directly to see the 5 Companies that are Buying Back Their Stock in 2022. So far in 2022, we have seen a number of […]
Boyar Research's Jonathan Boyar joins Yahoo Finance Live to discuss low stock valuations, the stock market, and his stock picks in the financial and tech sectors.
Mind Medicine (MindMed) Inc. ("MindMed") (NASDAQ: MNMD) (NEO: MMED), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, today announced the pricing of its underwritten public offering of 7,058,823 common shares, together with accompanying warrants to purchase 7,058,823 common shares. The combined offering price to the public of each common share and accompanying warrant is $4.25. Each common share will be sold in combination with an accompanying
Creating reliable streams of retirement income is one of the most important elements of a person's financial plan. A retirement industry giant says it now has a new way for retirees to meet this vital challenge. Fidelity Investments plans to … Continue reading → The post There's a New Way to Convert Your 401(k) into a Pension-like Stream of Income appeared first on SmartAsset Blog.
The benchmark S&P 500, which is typically viewed as the best barometer of stock market health, produced its worst first-half return in 52 years. As for the growth-driven Nasdaq Composite, an index largely responsible for pushing the stock market to new highs, it's lost about a third of its value. This puts both the S&P 500 and Nasdaq firmly in a bear market.
In this article, we discuss 12 best Asian stocks to buy today. If you want to read about some more Asian stocks, go directly to 5 Best Asian Stocks To Buy Today. Higher energy and food prices are impacting the economies of developing Asian countries more than the rest of the world. According to a […]
In this article, we will discuss the 10 dividend paying stocks you should avoid according to Morgan Stanley’s quant screen. If you want to read about similar stocks, you can also take a look at 5 Dividend Paying Stocks You Should Avoid According to Morgan Stanley’s Quant Screen. Morgan Stanley’s Sherry Paul: “It’s a Buying […]
In this article, we discuss 11 best dividend aristocrat stocks to buy heading into recession. If you want to see more stocks in this selection, click 5 Best Dividend Aristocrat Stocks To Buy Heading Into Recession. Several of the world’s biggest economies face increasing recession risks as a result of the skyrocketing inflation and the […]
Biogen stock rips higher on a promising new drug. Here's what Wall Street is saying.
Yahoo Finance Live anchors discuss VF Corp. slashing its full-year outlook on weak demand.
My children have inherited $5 million of stock from their father (whose estate has not yet been dispersed after 11 months) leaving them with a 30% or so loss of value over which they have had no control. Is there … Continue reading → The post Ask an Advisor: My Kids Inherited $5 Million. How Should They Handle It? appeared first on SmartAsset Blog.
In this article, we will discuss the 10 dividend paying stocks to buy according to Morgan Stanley’s quant screen. If you want to explore similar stocks, you can also take a look at 5 Best Dividend Stocks to Buy According to Morgan Stanley’s Quant Screen. Morgan Stanley’s Base Case: S&P Falling to $3,400 by Year […]
Lockheed Martin (LMT) closed the most recent trading day at $399.74, moving -1.94% from the previous trading session.
Biogen stock catapulted Wednesday — bringing shares of other Alzheimer's plays with it — after its experimental treatment succeeded in a test.
For many retail investors, the events of late January 2021 will go down in legend. The year 2020 could be characterized as the rise of the retail investor. Amid the retail revolution, one voice rose to the top.